BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 27565169)

  • 1. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
    Ishitsuka R; Miyazaki J; Ichioka D; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Kawai K; Nishiyama H
    Clin Exp Nephrol; 2017 Aug; 21(4):732-740. PubMed ID: 27565169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the accuracy of estimated baseline serum creatinine for acute kidney injury diagnosis.
    Hatakeyama Y; Horino T; Nagata K; Kataoka H; Matsumoto T; Terada Y; Okuhara Y
    Clin Exp Nephrol; 2018 Apr; 22(2):405-412. PubMed ID: 28983757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three equations for estimating glomerular filtration rate as predictors of cisplatin-related acute kidney injury in lung cancer patients with normal renal function.
    Karaboyun K; İriağaç Y; Çavdar E; Avci O; Şeber ES
    J Cancer Res Ther; 2024 Jan; 20(1):144-149. PubMed ID: 38554312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin.
    van der Vorst MJDL; Neefjes ECW; Toffoli EC; Oosterling-Jansen JEW; Vergeer MR; Leemans CR; Kooistra MP; Voortman J; Verheul HMW
    BMC Cancer; 2019 Nov; 19(1):1066. PubMed ID: 31703649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
    Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
    PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study.
    Inoue T; Miyazaki J; Ichioka D; Narita S; Kageyama S; Sugimoto M; Mitsuzuka K; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Matsui Y; Fujie K; Habuchi T; Nishiyama H
    BMC Cancer; 2018 Mar; 18(1):290. PubMed ID: 29540229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study.
    McMahon KR; Harel-Sterling M; Pizzi M; Huynh L; Hessey E; Zappitelli M
    Pediatr Nephrol; 2018 Dec; 33(12):2311-2320. PubMed ID: 30218190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower Blood Pressure-Induced Renal Hypoperfusion Promotes Cisplatin-Induced Nephrotoxicity.
    Mizuno T; Hayashi T; Shimabukuro Y; Murase M; Hayashi H; Ishikawa K; Takahashi K; Yuzawa Y; Yamada S; Nagamatsu T
    Oncology; 2016; 90(6):313-20. PubMed ID: 27225867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Creatinine Back-Estimation in Cardiac Surgery Patients: Misclassification of AKI Using Existing Formulae and a Data-Driven Model.
    Bernardi MH; Schmidlin D; Ristl R; Heitzinger C; Schiferer A; Neugebauer T; Wrba T; Hiesmayr M; Druml W; Lassnigg A
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):395-404. PubMed ID: 26801479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome Definition Influences the Relationship Between Genetic Polymorphisms of
    Zazuli Z; Otten LS; Drögemöller BI; Medeiros M; Monzon JG; Wright GEB; Kollmannsberger CK; Bedard PL; Chen Z; Gelmon KA; McGoldrick N; Kitchlu A; Vijverberg SJH; Masereeuw R; Ross CJD; Liu G; Carleton BC; Maitland-van der Zee AH
    Genes (Basel); 2019 May; 10(5):. PubMed ID: 31083486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Contrast Media Volume-Glomerular Filtration Rate Ratio and Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Intervention.
    Celik O; Ozturk D; Akin F; Ayca B; Yalcın AA; Erturk M; Bıyık I; Ayaz A; Akturk IF; Enhos A; Aslan S
    Angiology; 2015 Jul; 66(6):519-24. PubMed ID: 25005762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C.
    Jelinek MJ; Lee SM; Wyche Okpareke A; Wing C; Koyner JL; Murray PT; Stadler WM; O' Donnell PH
    Clin Transl Sci; 2018 Jul; 11(4):420-427. PubMed ID: 29691991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum methodology for estimating baseline serum creatinine for the acute kidney injury classification.
    Thongprayoon C; Cheungpasitporn W; Kittanamongkolchai W; Srivali N; Ungprasert P; Kashani K
    Nephrology (Carlton); 2015 Dec; 20(12):881-6. PubMed ID: 26032233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent serum creatinine increase following contrast-induced acute kidney injury.
    Briguori C; Quintavalle C; De Micco F; Visconti G; Di Palma V; Napolitano G; Focaccio A; Condorelli G
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1185-1191. PubMed ID: 28799717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of five different renal recovery definitions for estimation of long-term outcomes of cardiac surgery associated acute kidney injury.
    Xu J; Xu X; Shen B; Zhuang Y; Liu L; Wang Y; Fang Y; Luo Z; Teng J; Wang C; Ronco C; Yu J; Ding X
    BMC Nephrol; 2019 Nov; 20(1):427. PubMed ID: 31752748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discrepancy between serum creatinine and cystatin C can predict renal function after treatment for postrenal acute kidney injury: multicenter study and pooled data analysis.
    Matsuki M; Tanaka T; Maehana T; Kyoda Y; Ichihara K; Hashimoto K; Yanase M; Matsukawa M; Adachi H; Takahashi S; Masumori N
    Clin Exp Nephrol; 2017 Oct; 21(5):852-857. PubMed ID: 28258496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
    Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
    BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast volume to estimated glomerular filtration rate ratio for prediction of contrast-induced acute kidney injury after cardiac catheterization in adults with congenital heart disease.
    Gellis L; Gauvreau K; Ferguson M; Bergersen L; Shafer K; Porras D
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1301-1308. PubMed ID: 30196559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of the Safety and Efficacy of First-Line Cisplatin and Carboplatin Chemotherapy in Elderly Patients with Metastatic Urothelial Carcinoma.
    Huang SY; Wu CC; Hsieh MC; Rau KM; Chiang PH; Sung MT; Luo HL; Huang CC; Huang CH; Liu JM; Su HY
    Oncology; 2020; 98(3):146-153. PubMed ID: 31794969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
    Yafi FA; Tanguay S; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Lacombe L; Chin J; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Kassouf W
    Urol Oncol; 2014 Jan; 32(1):31.e17-24. PubMed ID: 23428535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.